Mari Aso
Yamagata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Asymptomatic Pulmonary Involvement as the Initial Presentation of Vascular Ehlers-Danlos Syndrome with a Novel COL3A1 Frameshift Variant: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: May 17, 2026
Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001.
Journal: Japanese journal of clinical oncology
Published: September 24, 2024
Real-world first-line treatment with pembrolizumab for non-small cell lung carcinoma with high PD-L1 expression: Updated analysis.
Journal: Cancer medicine
Published: December 28, 2023
Transbronchial cryobiopsy using an ultrathin cryoprobe with a guide sheath for the diagnosis of pulmonary mucosa-associated lymphoid tissue lymphoma.
Journal: Journal of thoracic disease
Published: July 22, 2023
Nivolumab Therapy in Lung Cancer Associated with IgG4-related Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: May 31, 2023
Pituitary hypoadrenocorticism and hypothyroidism after immunochemotherapy followed by salvage surgery for lung cancer: a case report.
Journal: General thoracic and cardiovascular surgery cases
Published: August 04, 2022
Atezolizumab-associated Dermatomyositis in Advanced Small-cell Lung Carcinoma.
Journal: Internal medicine (Tokyo, Japan)
Published: March 29, 2021
Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer.
Journal: Cancer medicine
Published: February 03, 2021
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer.
Journal: The oncologist
Published: July 22, 2019
Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab.
Journal: JMA journal
Published: January 15, 2019
Last Updated: 09/26/2026